Clinical Trials - QNRX

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06953466Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeRECRUITINGPHASE2, PHASE32025-072026-07-302026-07-30
NCT05789056Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeRECRUITINGPHASE2, PHASE32023-03-142025-12-302025-12-30
NCT05521438Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeRECRUITINGPHASE2, PHASE32022-06-232025-12-312025-12-31